Nano-lipid particles of naproxen for topical application: In vitro / in vivo study
DOI:
https://doi.org/10.56511/JIPBS.2019.v6.i01.pp31-36Abstract
Nano lipid particles (Nps) based Naproxen gels (Npx) have been developed as a promising topical delivery system for osteoarthritis treatment. Six formulas were developed with different polymer ratios using hot high pressure homogenization method. The characterizations of Npx-Nps for topical application were assessed for physical characteristics. Furthermore, in vitro transdermal release and the in vivo analgesic effect of the selected formula based on drug loading results (Npx-Np5) was carried out. The mean particle size was ranged between 203±10 nm and 228±30 nm for Npx1 and Npx4 respectively. Npx-Np5 showed highest drug loading (9.8±2.23%) and encapsulation capacity (98.0±3.9%). In vitro release study through rat skin showed that Npx-Nps5 had a more pronounced permeation profile compared with commercial gel. Moreover, the analgesic effect induced by Npx-Np5-carbapol gel was 1.5 times higher than that induced by Naprosyn 10%gel after 4 h. Lipid nanoparticles are carriers with good prospects of successful marketing.
Keywords:
Analgesic activity, Naproxen, Nano lipid particles, Osteoarthritis, Tail flick methodDownloads
References
Peter A. Todd, Stephen P. Clissold. Naproxen. A Reappraisal of its Pharmacology, and Therapeutic Use in Rheumatic Diseases and Pain States. Drugs 1990; 40( 1 ):91 – 137.
Khosro A. Yousef, Javadzadehab Siavoush, Dastmalchiab Ghobad, Mohammadic Fatemeh, Kari Niria , Mahmood AlaeiBeiramia . Naproxen – eudragit ® RS100 nanoparticles: Preparation and physicochemical characterization. Colloids Surf. B: Biointerfaces 2011; 83:155 – 159.
Dhumal RS., Paradkar AR., Kadam SS. Effect of drying methods on swelling, erosion and drug release from chitosan-naproxen sodium complexes AAPS Pharm Sci Tech. 2008; 9:1 – 12.
Fei Han, Ran Yin, Xin Che, Jing Yuan, Yanan Cui, He Yin, Sanming Li. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: Design, characterization and in vivo evaluation. Int. J. of Pharmaceutics, 2012; 439: 349 – 357.
Araujo J, Garcia ML, Mallandrich M, Souto EB, Calpena AC. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies. Int. J Nanomedicine 2012; 8 (6):1034 – 1041.
Farboud ES, Nasrollahi SA, Tabbakhi Z. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies. Int J Nanomedicine 2011; 6:611 – 617.
Araújo J, Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm. 2010; 393(12):167-75.
Gert Fricker TK and Wendel A. Phospholipids and LipidBased Formulations in Oral Drug Delivery. Pharm Res. 2010; 230:71-85.
Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W and Shi Y. Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. J. Powder Technology 2010; 197:120 – 128.
Liu C. and Wu C. Optimization of nanostructured lipid carriers for lutein delivery. J. Coll Surf A: Physicochem Eng. Aspects 2008; 353: 149-156.
Guo C., Yang C., Li Q., Tan Q., Liu, W., Zhai, G. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int. J. Pharm. 2012; 430:292 – 298. 6 8 Np carbapol gel Naprosyn 10% gel
Vitorino C., Carvalho F. Almeida A. The size of solid lipid nanoparticles: an interpretation from experimental design. J. Colloids Surf B Biointerfaces 2011; 84:117 – 30.
Bilal Y., Ali A. and Ali F. Erdem. HPLC Method for Naproxen Determination in Human Plas ma and Its Application to a Pharmacokinetic Study in Turkey. J. Chromatographic Science 2014; 52:584 – 589.
Okur N., Yava ş o ğ lu A., Karasulu H., Preparation and Evaluation of Microemulsion Formulations of Naproxen for Dermal Delivery. J. Chem. Pharm. Bull. 2014; 62(2): 135 – 143.
Ibrahim, M., Amin, M., Fetih, G., AbouEla, A. Formulation and evaluation of ketorolac tromethamine-Eudragit solid dispersions of potential sustained release properties. J. Pharm Practic. 2010; 20:189-200.
Saleem, M., Darbar, S., Mahesh, G., Rani, S. Analgesic, antipyretic and anti-inflammatory activity of dietary sesame oil in experimental animal models. J. Pharm. 2011; 2:172 – 177.
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. J Acta Pol Pharm. 2010; 67:217 – 223.
Mulla J., Khazi I., Jamakandi, V., Solid lipid nanoparticles: Potential applications. IJNDD. Technology 2009; 197: 120-128.
Jenning, V., Gysler, A., Schafer-Korting, M., Gohla, S.H., Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 2000; 49: 211 – 218.
Pardeike, J., Hommoss, A., Müller, R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009; 366: 170 – 184.
Jafar A., Majid S., Katayoun M., Seyyed S., Masoumeh A., Kofi A.- Addoe, Ali Nokhodchi. The design of naproxen solid lipid nanoparticles to target skin layers. J. Colloids and Surfaces B: Biointerfaces 2016; 145: 626 – 633.
Ar gemı´ A, Ellis JL, Saurina J, Tomasko DL. Development of a polymeric patch impregnated with naproxen as a model of transdermal sustained release system. J Pharm Sci. 2011; 100:992 – 1000.
Amal El Sayeh F. Abou el Ela , Maha A. Hassan , Dalia A. ElMaraghy. Ketorolac tromethamine floating beads for oral application: Characterization and in vitro/in vivo evaluation. Saudi Pharm J. 2014; 22(4):349-59.
Published
How to Cite
Issue
Section
Copyright (c) 2019 Dalia A. Gaber
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at